All news

Why the US Cannabis Industry May Witness a $20 Billion Boom

The $867 billion farm bill paves the way for America's hemp industry to really start blazing

Perceptions of plain cannabis packaging and health warning labels for cannabis among young adults

This issue is of particular importance in light of the recent legalization of recreational cannabis in Canada. The current study examined perceptions of plain packaging and HWLs for cannabis packages among young adults

Green progress: WA's first medicinal cannabis-specific clinic opens

Subiaco is now home to WA's first cannabis-centric GP clinic

Some licensed producers are selling cannabis oils that are placebos: researchers

A biopharmaceutical company hoping to disrupt the cannabis extraction market is claiming some Canadian licensed producers are selling cannabis oils that are tantamount to placebos

New Zealand legalises medicinal cannabis

NZ MPs have voted through a bill that will see medicinal cannabis production legalised and that some hope will spark a new industry in struggling towns.

Parents who gave cannabis oil treatment to son to treat autism have no convictions recorded

Jamie Blake and Stephanie Mackay, who were charged after growing their own cannabis to treat their son for autism, escape conviction despite pleading guilty.

Even without proof, CBD is finding a niche as a cure-all

Supporters say cannibidiol, which comes from the hemp plant, can treat pain, anxiety, inflammation and even cancer. But it might just be snake oil

Kiwis support medicinal cannabis for many conditions: Poll

A majority of New Zealanders say medicinal cannabis should be allowed to treat chronic pain, sleep disorders and other conditions, according to a new poll

Canadian doctors call for more education when it comes to prescribing cannabis

Physician-reported knowledge gaps in cannabis education is starting to gain attention

A look at where companies stand on cannabis business

When Canada legalised recreational cannabis in October, it emerged as the world leader in the industry — and U.S. companies are scrambling to get in on the action